Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome

Journal of the American Academy of Dermatology

Volumn 58, Issue 4, 2008, Pages 592-595

  Introcaso, Camille E ^a   Micaily, Bizhan ^b   Richardson, Stephen K ^a   Junkins Hopkins, Jacqueline M ^a   Yoon, Jessica S ^a   Kim, Ellen J ^a   Vittorio, Carmela C ^a   Rook, Alain H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BEXAROTENE;

ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ELECTRON THERAPY; ERYTHEMA; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; PRURITUS; PUVA; SEZARY SYNDROME; TREATMENT DURATION; TREATMENT RESPONSE;

CD4-CD8 RATIO; COMBINED MODALITY THERAPY; ELECTRONS; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; LYMPHOMA, T-CELL, CUTANEOUS; MYCOSIS FUNGOIDES; SEZARY SYNDROME; SKIN NEOPLASMS; T-LYMPHOCYTES; WHOLE-BODY IRRADIATION;

EID: 40649100257     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.12.016     Document Type: Article

References (12)

1. Kim E., Hess S., Richardson S., Newton S., Showe L.C., Benoit B.M., et al. Immunopathogenesis and therapy of cutaneous T-cell lymphoma. J Clin Invest 115 (2005) 798-812
2. Kim Y., Liu H., Mraz-Gernhard S., Varghese A., and Hoppe R.T. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 139 (2003) 857-866
3. Richardon S., Lin J., Vittorio C., Kim E.J., Yoon J.S., Junkins-Hopkins J.M., et al. High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome. Clin Lymphoma Myeloma 7 (2006) 226-232
4. Jones G.W., Kacinski B.M., Wilson L.D., Willemze R., Spittle M., Hohenberg G., et al. Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer cutaneous lymphoma project group. J Am Acad Dermatol 47 (2002) 364-370
5. Wilson L.D., Jones G.W., Kim D., Rosenthal D., Christensen I.R., Edelson R.L., et al. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol 43 (2000) 54-60
6. Jones G.W., Rosenthal D., and Wilson L.D. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome). Cancer 85 (1999) 1985-1995
7. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti B., Swerlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
8. Olsen E., Vonderheid E., Pimpinelli N., Willemze R., Kim Y., Knobler R., et al. Revised staging and classification of MF/SS. Blood 110 (2007) 1713-1722
9. In: Perez C.A., and Brady L.W. (Eds). Principles and practices of radiation oncology (1998), Lippincott-Raven, Philadelphia
10. Oyekunle A., Kroger N., Zabelina T., Ayuk F., Schieder H., Renges H., et al. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Bone Marrow Transplant 37 (2006) 45-50
11. Molina A., Zain J., Arber D., Angelopolou M., O'Donnell M., Murata-Collins J., et al. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sézary syndrome and mycosis fungoides. J Clin Oncol 23 (2005) 6163-6171
12. Yoo E., Cassin M., Lessin S., and Rook A.H. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol 45 (2001) 208-216